跳至主要内容
临床试验/NCT05551169
NCT05551169已完成不适用

Establishment of an Algorithm That Can Detect and Infer the Severity Level of COPD by Intelligent Terminal Device

Peking University First Hospital10 个研究点 分布在 1 个国家目标入组 432 人开始时间: 2022年6月21日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
432
试验地点
10
主要终点
Stage 1: Association between the severity of COPD airflow restriction and data collected by wearable devices

研究概览

简要总结

Chronic obstructive pulmonary disease (COPD) is one of the most common respiratory diseases. Early detection and treatment are critical to prevent the deterioration of COPD. In this study, investigators aim to develop an algorithm that can detect and infer the severity level of COPD from physiological parameters and audio data which are collected by a wearable device. Investigators will complete the study in two stages: stage 1. A panel study to assess the ability to infer the severity of COPD by intelligent terminal devices; stage 2. Establish an algorithm that can detect and infer the severity level of COPD by intelligent terminal devices.

详细描述

In this study, investigators aim to establish an algorithm that can detect and infer the severity level of COPD from physiological parameters, coughing sounds, and forceful blowing sounds data that are collected by wearable devices.

This study is divided into two stages. Stage one: A panel study to assess the ability to infer the severity of COPD by intelligent terminal devices. 30 patients with stable COPD will be enrolled and will undergo pulmonary function tests, electrocardiogram, echocardiography measurement, blood gas analysis, six-minutes walking test (6MWT), and polysomnography. And they are required to fill in the questionnaires related to COPD every day. Physiological parameters including oxygen saturation, heart rate, sleep, and physical activity will be collected by a wearable device for 7-14 consecutive days. Coughing and forceful blowing sounds will be collected twice daily. The association between the severity of COPD and physiological parameters from the wearable device will be analyzed.

Stage two: Establish an algorithm that can detect and infer the severity level of COPD by intelligent terminal devices. 200 patients with stable COPD and 200 non- COPD subjects will be enrolled. Questionnaires related to COPD will be collected, and subjects will undergo pulmonary function tests and electrocardiograms. Physiological parameters including oxygen saturation and heart rate will be continuously collected by a wearable device for about 3~7 days. Investigators will also collect coughing and forceful blowing sounds. A COPD diagnosis algorithm model based on physiological parameters and audio data of intelligent terminal devices will be established.

The study protocol has been approved by the Peking University First Hospital Institutional Review Board (IRB) (2022-083). Any protocol modifications will be submitted for IRB review and approval.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Stage 1: Association between the severity of COPD airflow restriction and data collected by wearable devices

时间窗: 2 months

Association between the severity of COPD airflow restriction and data collected by wearable devices

Stage 2:Establish an algorithm that can detect and infer the severity level of COPD by intelligent terminal devices

时间窗: 5 months

Establish an algorithm that can detect and infer the severity level of COPD by intelligent terminal devices

次要结局

  • Stage 1: Association between the severity of COPD airflow restriction, CAT score, mMRC score, echocardiography, blood gas analysis, six-minutes walking distance, polysomnography,and data collected by wearable devices(2 months)
  • Stage 1: The compliance of subjects with wearable devices(2 months)
  • Stage 2: Association between the severity of COPD airflow restriction, CAT score, mMRC score,and data collected by wearable devices(5 months)
  • Stage 2: number of adverse events(5 months)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Guangfa Wang

Prof. & MD.

Peking University First Hospital

研究点 (10)

Loading locations...

相似试验